Contact Us
Filling this form is the simpliest way to contact us by email.
If you wish to visit us, please click here for full maps and details.
© 2002 Immutep, S.A.
On this page: |
Contact UsFilling this form is the simpliest way to contact us by email. If you wish to visit us, please click here for full maps and details. © 2002 Immutep, S.A.
|
Press Release
06/2008 - LAG-3 Enhances Activity of a Cellular Cancer Immunotherapy
11/2007 - IMP321 first results in metastatic breast cancer 09/2007 - IMP321’s potency as a new immunopotentiator in cancer patients 09/2007 - Entering Phase I 10/2006 - Entering Phase I |
|||||||||||||||||||